Company profile
Heartflow, Inc. Common Stock
NASDAQ: HTFL · Healthcare · Medical - Healthcare Information Services
#298 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
44DFH 68DQ 5GM —SS 59
v0.1 · 55/100 weight · provisional
↑ Altman-Z, market scale · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$191.4M
Rev growth YoY (TTM)
+40.6%
Net income (FY)
-$116.8M
Employees
843
as of 2026-08-08
Market cap
$2.5B
as of 2026-08-08
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$176.0M$176.0M2025
Net income-$116.8M-$116.8M2025
Operating income-$64.1M-$64.1M2025
Total assets$359.5M$359.5M2025
Liabilities$58.8M$58.8M2025
Equity$300.6M$300.6M2025
Revenue trend
FY2025 – FY2025 · USD
FY25
FY25
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Heartflow, Inc. Common Stock’s revenue?
Heartflow, Inc. Common Stock booked $176.0M in FY2025 revenue, growing 40% year over year — faster than most Healthcare companies we track, at a -66.3% net margin.
Peers · Healthcare
Rhythm Pharmaceuticals, Inc.60CMaravai LifeSciences Holdings, Inc.53DStoke Therapeutics, Inc.60CPhathom Pharmaceuticals, Inc.47DSyndax Pharmaceuticals, Inc.52DREGENXBIO Inc.54DNeighbors
Santa Clara →Key facts
CEOJohn Farquhar
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersMountain View, CA
ExchangeNASDAQ: HTFL
Employees843
IPO date2025-08-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.